Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells
Open Access
- 18 August 2005
- journal article
- technology development
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 24 (2), 462-471
- https://doi.org/10.1634/stemcells.2004-0331
Abstract
Mesenchymal stem cells (MSCs) are multipotent cells defined by multilineage potential, ease to gene modification, and immunosuppressive ability, thus holding promise for tissue engineering, gene therapy, and immunotherapy. They exhibit a unique in vitro expansion capacity, which, however, does not compensate for the very low percentage in their niches given the vast numbers of cells required for the relative studies. Taking into consideration the lack of a uniform approach for MSC isolation and expansion, we attempted in this study, by comparing various culture conditions, to identify the optimal protocol for the large-scale production of MSCs while maintaining their multilineage and immunosuppressive capacities. Our data indicate that, apart from the quality of fetal calf serum, other culture parameters, including basal medium, glucose concentration, stable glutamine, bone marrow mononuclear cell plating density, MSC passaging density, and plastic surface quality, affect the final outcome. Furthermore, the use of basic fi-broblast growth factor (bFGF), the most common growth supplement in MSC culture media, greatly increases the proliferation rate but also upregulates HLA-class I and induces low HLA-DR expression. However, not only does this upregulation not elicit significant in vitro allogeneic T cell responses, but also bFGF-cultured MSCs exhibit enhanced in vivo immunosuppressive potential. Besides, addition of bFGF affects MSC multilineage differentiation capacity, favoring differentiation toward the osteogenic lineage and limiting neurogenic potential. In conclusion, in this report we define the optimal culture conditions for the successful isolation and expansion of human MSCs in high numbers for subsequent cellular therapeutic approaches.Keywords
This publication has 46 references indexed in Scilit:
- Isolation of a Highly Clonogenic and Multipotential Subfraction of Adult Stem Cells from Bone Marrow StromaThe International Journal of Cell Cloning, 2004
- Effect of Culture Substrates and Fibroblast Growth Factor Addition on the Proliferation and Differentiation of Rat Bone Marrow Stromal CellsTissue Engineering, 2004
- Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarctionThe American Journal of Cardiology, 2004
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Mesenchymal stem cells: clinical applications and biological characterizationThe International Journal of Biochemistry & Cell Biology, 2004
- Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsTransplantation, 2003
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsExperimental Hematology, 2003
- Retention of Multilineage Differentiation Potential of Mesenchymal Cells during Proliferation in Response to FGFBiochemical and Biophysical Research Communications, 2001
- Systemic Injection of FGF-2 Stimulates Endocortical Bone Modelling in SAMP6, a Murine Model of Low Turnover Osteopenia.The Journal of Veterinary Medical Science, 1999
- Single-Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In VivoJournal of Bone and Mineral Research, 1997